We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Patient Safety Goals for U.S. Labs Detailed for 2009

By Labmedica staff writers
Posted on 24 Jun 2008
A 2009 update of a U.S. More...
national patient safety goals report and related requirements for accredited laboratories, promote specific improvements in patient safety by providing healthcare organizations with proven solutions to persistent patient safety problems.

The Joint Commission (Oakbrook Terrace, IL, USA) announced the modification of The National Patient Safety Goals, which is overseen by the Sentinel Event Advisory Group, a panel that includes patient safety experts, nurses, physicians, pharmacists, and risk managers, who have hands-on experience in addressing patient safety issues in hospitals and other healthcare settings. The goals apply to the more than 15,000 Joint Commission-accredited and -certified health care organizations and programs in the United States.

The Joint Commission also accredits health plans, integrated delivery networks, and other managed care entities. In addition, it provides certification of disease-specific care programs, primary stroke centers, and health care staffing services. An independent, not-for-profit organization, The Joint Commission is the nation's oldest and largest standards setting and accrediting body in health care.

The guidelines include emphasis on correct identification of the patient, especially before invasive procedures; verification that the patient correctly receives all test results; communication between caregivers is improved; hand hygiene guidelines are monitored; and that the patient takes an active interest in his/her own care.

"The 2009 National Patient Safety Goals represent ongoing opportunities for improvement that can immediately benefit patients,” said Mark R. Chassin, M.D., M.P.P., M.P.H., president, The Joint Commission. "By taking action to consistently meet the Goals, health care organizations can substantially improve patient safety in America.”

The Joint Commission seeks to continuously improve the safety and quality of care provided to the public through the provision of healthcare accreditation and related services that support performance improvement in healthcare organizations. The Joint Commission evaluates and accredits more than 15,000 healthcare organizations and programs in the United States, including more than 8,000 hospitals and home care organizations, and more than 6,300 other healthcare organizations that provide long-term care, assisted living, behavioral healthcare, laboratory, and ambulatory care services


Related Links:
The Joint Commission

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gastrointestinal Panel
Xpert® GI Panel
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.